Skip to main content

Advertisement

Log in

Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

In our previous study, we found that glucocorticoid receptor (GR) gene genetic polymorphisms may play a major role in the efficacy of glucocorticoids (GCs) in Chinese systemic lupus erythematosus (SLE) patients. The aim of this study is to explore the association of GR gene genetic polymorphisms and improvement of health-related quality of life (HRQOL) in Chinese SLE patients treated with GCs. A total of 195 Chinese SLE patients were treated with GCs for 12 weeks. The HRQOL of patients was measured with the Medical Outcomes Study Short Form-36 (SF-36) at baseline and 12 weeks. Polymorphisms of GR gene were genotyped by using multiplex SNaPshot method. One hundred eighty-four patients (94.36 %) completed the 12-week follow-up. Twenty-three single-nucleotide polymorphisms of GR gene were genotyped. There was a significant association between rs10482672 polymorphism and improvement in physical function (P = 0.043), general health (P = 0.024), and social function (P = 0.013). The rs12656106 polymorphism was associated with improvement in the total score of SF-36 (P = 0.014), physical function (P = 0.013), general health (P = 0.010), vitality (P = 0.015), social function (P = 0.004), physical component summary (P = 0.016), and mental component summary (P = 0.014). The rs4912905 polymorphism was associated with improvement in bodily pain (P = 0.040) and general health (P = 0.038). The rs4912911 polymorphism was associated with improvement in general health (P = 0.026) and vitality (P = 0.027). The rs4986593 polymorphism was associated with improvement in bodily pain (P = 0.034). The rs7719514 polymorphism was associated with improvement in vitality (P = 0.002) and mental component summary (P = 0.041). We also found a significant association between rs9324924 polymorphism and improvement in physical function (P = 0.040), bodily pain (P = 0.007), and general health (P = 0.019). These results indicate that there may be an association of GR gene rs10482672, rs12656106, rs4912905, rs4912911, rs4986593, rs7719514, and rs9324924 polymorphisms with improvement of HRQOL in Chinese SLE patients treated with GCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. D’Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369:587–596

    Article  PubMed  Google Scholar 

  2. van Rossum EF, van den Akker EL (2011) Glucocorticoid resistance. Endocr Dev 20:127–136

    PubMed  Google Scholar 

  3. Zou YF, Xu JH, Wang F et al (2013) Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: a prospective cohort study. Autoimmunity 46:531–536

    Article  CAS  PubMed  Google Scholar 

  4. Zou YF, Xu JH, Tao JH et al (2013) Impact of environmental factors on efficacy of glucocorticoids in chinese population with systemic lupus erythematosus. Inflammation 36:1424–1430

    Article  CAS  PubMed  Google Scholar 

  5. Adcock IM, Nasuhara Y, Stevens DA et al (1999) Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol 127:1003–1011

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Francke U, Foellmer BE (1989) The glucocorticoid receptor gene is in 5q31-q32 [corrected]. Genomics 4:610–612

    Article  CAS  PubMed  Google Scholar 

  7. Encío IJ, Detera-Wadleigh SD (1991) The genomic structure of the human glucocorticoid receptor. J Biol Chem 266:7182–7188

    PubMed  Google Scholar 

  8. WHOQOL Group (1993) Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 2:153–159

    Article  Google Scholar 

  9. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  10. Newnham EA, Harwood KE, Page AC (2007) Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. J Affect Disord 98:91–97

    Article  PubMed  Google Scholar 

  11. Thumboo J, Strand V (2007) Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singap 36:115–122

    PubMed  Google Scholar 

  12. Galon J, Franchimont D, Hiroi N et al (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61–71

    Article  CAS  PubMed  Google Scholar 

  13. Mosca M, Tani C, Carli L et al (2011) Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol 29:S126–S129

    CAS  PubMed  Google Scholar 

  14. Nicolaides NC, Galata Z, Kino T et al (2010) The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75:1–12

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Manenschijn L, van den Akker EL, Lamberts SW et al (2009) Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci 1179:179–198

    Article  CAS  PubMed  Google Scholar 

  16. Dua AB, Touma Z, Toloza S et al (2013) Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep 15:380

    Article  PubMed  Google Scholar 

  17. Moldovan I, Katsaros E, Carr FN et al (2011) The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus 20:1285–1292

    Article  CAS  PubMed  Google Scholar 

  18. Anacker C, Zunszain PA, Carvalho LA et al (2011) The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 36:415–425

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Gałecka E, Szemraj J, Bieńkiewicz M et al (2013) Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland. Mol Biol Rep 40:1693–1699

    Article  PubMed Central  PubMed  Google Scholar 

  20. Hauer D, Weis F, Papassotiropoulos A et al (2011) Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit Care Med 39:643–650

    Article  CAS  PubMed  Google Scholar 

  21. Rostami S, Parsa-Yekta Z, Najafi-Ghezeljeh T et al (2015) Self-perception in Iranian adolescents with diabetes: a qualitative study. J Diabetes Metab Disord 14:36

    Article  PubMed Central  PubMed  Google Scholar 

  22. Yang J, Lu YW, Pan HF et al (2012) Seasonal distribution of systemic lupus erythematosus activity and its correlation with climate factors. Rheumatol Int 32:2393–2399

    Article  PubMed  Google Scholar 

  23. Sun S, Chen J, Johannesson M et al (2011) Regional differences in health status in China: population health-related quality of life results from the National Health Services Survey 2008. Health Place 17:671–680

    Article  PubMed  Google Scholar 

  24. Costedoat-Chalumeau N, Amoura Z, Hulot JS et al (2007) Hydroxychloroquine in systemic lupus erythematosus. Lancet 369:1257–1258

    Article  PubMed  Google Scholar 

  25. Petri M (2011) Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients. Curr Rheumatol Rep 13:77–80

    Article  CAS  PubMed  Google Scholar 

  26. Carmichael SJ, Charles B, Tett SE (2003) Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Ther Drug Monit 25:671–681

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all patients for their enthusiastic participation in the study. This work was supported by grants from the National Natural Science Foundation of China (81373073, 81172764, 81102192, 81273169).

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dong-Qing Ye.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM. 1

(DOC 55 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zou, YF., Xu, JH., Pan, FM. et al. Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus. Clin Rheumatol 34, 1537–1544 (2015). https://doi.org/10.1007/s10067-015-3027-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-3027-6

Keywords

Navigation